Combined Divisions of Plastic Surgery at the University Hospitals of Cornell and Columbia, New York-Presbyterian Hospital, New York, NY, USA.
Aesthetic Plast Surg. 2011 Dec;35(6):1079-86. doi: 10.1007/s00266-011-9738-4. Epub 2011 May 11.
Axillary hyperhidrosis is a debilitating disease that affects the social and occupational lives of many Americans. It can be treated with subdermal injections of botulinum toxin. This study aimed to determine the interval between injections during which patients are symptom free and whether that interval varies depending on the number of treatments a patient has received.
The study enrolled all the patients treated with botulinum toxin for axillary hyperhidrosis by the senior author between 2004 and 2010. Patient responses to the treatment with regard to both satisfaction and length of the symptom-free interval were collected prospectively and analyzed. An in-depth PubMed search was performed through July 2010 to compile the published data on using botulinum toxin injections to treat axillary hyperhidrosis. These data served as a benchmark to which the trends at our institution were compared.
The 53 patients included in the study had an average age of 29 years, and 64% were women. Of the 53 patients, 23 (43%) underwent multiple injections of botulinum toxin. The average symptom-free interval was 261 days. There was no statistically significant difference in symptom-free intervals after multiple treatments. Patient satisfaction rates were very high, similar to the high degrees of satisfaction found in the published data.
Botulinum toxin injections provide an effective treatment for axillary hyperhidrosis with a rapid onset and high patient satisfaction. Many patients have a symptom-free interval of 6-9 months after each botulinum toxin injection. This interval does not change significantly after multiple treatments.
腋下多汗症是一种使人衰弱的疾病,会影响许多美国人的社交和职业生活。它可以通过皮下注射肉毒杆菌毒素来治疗。本研究旨在确定患者在无症期间隔,以及该间隔是否因患者接受的治疗次数而异。
本研究纳入了 2004 年至 2010 年间由资深作者用肉毒杆菌毒素治疗腋下多汗症的所有患者。前瞻性收集了患者对治疗的反应,包括满意度和无症状间隔时间,并进行了分析。截至 2010 年 7 月,通过深入的 PubMed 搜索,编译了关于使用肉毒杆菌毒素注射治疗腋下多汗症的已发表数据。这些数据作为基准,与本机构的趋势进行了比较。
本研究纳入的 53 例患者平均年龄 29 岁,64%为女性。53 例患者中有 23 例(43%)接受了多次肉毒杆菌毒素注射。平均无症状间隔为 261 天。多次治疗后的无症状间隔无统计学差异。患者满意度非常高,与已发表数据中发现的高满意度相似。
肉毒杆菌毒素注射为腋下多汗症提供了一种有效治疗方法,起效迅速,患者满意度高。许多患者在每次肉毒杆菌毒素注射后有 6-9 个月的无症状间隔。多次治疗后该间隔无明显变化。